China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Net Income	-14.14	-5.93	-5.74	-2.75	-10.29	1.54
Depreciation & Amortization	0.35	0.32	0.32	0.35	0.33	0.18
Share-Based Compensation	0.28	0.55	2.33	0	0	0
Other Operating Activities	13.4	4.98	3.35	1.09	10.89	-1.48
Operating Cash Flow	-0.11	-0.08	0.27	-1.32	0.93	0.24
Operating Cash Flow Growth	-	-	-	-	290.58%	-87.54%
Capital Expenditures	-0.05	-0.07	-0.06	-0.09	-0.41	-0.6
Acquisitions	0.02	0.06	0.02	3.13	-3.59	0
Change in Investments	-	0	0	-8.85	-1.5	0
Other Investing Activities	-	-	-	-	-	-0.01
Investing Cash Flow	-0.03	-0.01	-0.05	-5.81	-5.5	-0.61
Share Issuance / Repurchase	-	2.19	3.09	0	0	6.49
Debt Issued / Paid	0.87	0.75	-1.49	12.41	6.72	0.07
Other Financing Activities	8.67	-	-	-	-3.7	2.48
Financing Cash Flow	9.55	2.94	1.6	12.41	3.02	9.04
Exchange Rate Effect	-0.92	-1.05	0.39	0.78	-0.47	-0.04
Net Cash Flow	8.48	1.8	2.21	6.07	-2	8.63
Free Cash Flow	-0.16	-0.15	0.21	-1.41	0.53	-0.36
Free Cash Flow Margin	-540.69%	-450.44%	60.69%	-159.28%	159.67%	-169.51%
Free Cash Flow Per Share	-0.32	-0.57	4.95	-48.98	42.67	-34.97

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).